Form 4: Scilex Holding Co Director Followwill Dorman Acquires 100,000 Stock Options

Director Followwill Dorman of Scilex Holding Co acquired 100,000 nonstatutory stock options at an exercise price of $0.5045 on December 16, 2024.

Summary

• On December 16, 2024, Followwill Dorman, a director at Scilex Holding Co, was granted 100,000 nonstatutory stock options.
• The exercise price for these options is $0.5045 per share.
• The options vest monthly over a period of 12 months, contingent on Dorman's continued service to the company.
• The options expire on December 16, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications or unusual circumstances.

Positives

• The grant of stock options to a director aligns their interests with the company's performance and shareholder value.
• The vesting schedule encourages continued service and commitment from the director.

Industry Context

This is a standard practice for incentivizing directors and aligning their interests with the company's long-term success. Stock option grants are common in the biotech and pharmaceutical industries.

Comparison to Industry Standards

• Stock option grants to directors are a common practice across various industries, particularly in growth-oriented sectors like biotech.
• The vesting schedule of 12 months is fairly standard, designed to retain talent and align incentives with company performance.
• The exercise price of $0.5045 is specific to Scilex Holding Co and would need to be compared to other similar companies to assess its relative value.

Stakeholder Impact

• The stock option grant could positively impact shareholder value if the director's performance contributes to the company's success.
• The vesting schedule encourages the director's continued service, which benefits the company and its stakeholders.

Key Dates

Keywords

stock options, insider trading, Scilex Holding Co, Followwill Dorman, director, equity, vesting